Add like
Add dislike
Add to saved papers

Observation of nanotwinning and room temperature ferromagnetism in sub-5 nm BiFeO 3 nanoparticles: a combined experimental and theoretical study.

Particle size significantly affects the properties and therefore the potential applications of multiferroics. However, is there special particle size effect in BiFeO3 , which has a spiral modulated spin structure? This is still under investigation for sub-5 nm BiFeO3 . In this report, the structural, electronic and magnetic properties are investigated for chemically synthesized BiFeO3 nanoparticles with an average size of 3 nm. We observed nanotwinning features in the specific size regime of the nanoparticles (2-4 nm). A weak Bi-O-Fe coordination and weak covalent nature has been observed in the nanoparticles through high-resolution electron energy loss spectroscopy and theoretical analysis, confirming that BiFeO3 nanoparticles a retain rudimentary R3c phase even at sub-5 nm dimensions. The R3c phase of sub-5 nm BiFeO3 nanoparticles has also been confirmed using Raman spectroscopy and Raman mapping of the vibrational modes. The nanoparticles display cluster spin glass, room temperature ferromagnetism, and a metamictization-davidite phase. The observation of weak magnetic entropy features confirmed the presence of a weak correlation between the magnetic and ferroelectric components. To support our experimental observations, we have simulated a sub-5 nm BiFeO3 nanocluster. Using density functional theory, the ferromagnetic ground state and the presence of a weak covalent nature in the nanocluster is established considering the first Brillouin zone, thus confirming our experimental results. Finding of new physicochemical features in sub-5 nm BiFeO3 would be beneficial for the understanding of the fundamental physical and chemical science as well as potential device development.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app